Literature DB >> 28820702

Predictive Model for Permanent Shunting in Cryptococcal meningitis.

Woralux Phusoongnern1, Siriluck Anunnatsiri2, Kittisak Sawanyawisuth3,4,2, Amnat Kitkhuandee1.   

Abstract

Cryptococcal meningitis may have long-term morbidity and requires a permanent cerebrospinal fluid shunt. This study aimed to evaluate the risk factors and create a predictive model for permanent shunt treatment in cryptococcal meningitis patients. This was a retrospective analytical study conducted at Khon Kaen University. The study period was from January 2005 to December 2015. We enrolled all adult patients diagnosed with cryptococcal meningitis. Risk factors predictive for permanent shunting treatment were analyzed by multivariate logistic regression analysis. There were 341 patients diagnosed with cryptococcal meningitis. Of those, 64 patients (18.7%) were treated with permanent shunts. There were three independent factors associated with permanent shunt treatment. The presence of hydrocephalus had the highest adjusted odds ratio at 56.77. The resulting predictive model for permanent shunt treatment (y) is (-3.85) + (4.04 × hydrocephalus) + (2.13 × initial cerebrospinal fluid (CSF) opening pressure (OP) > 25 cm H2O) + (1.87 × non-human immune deficiency vrus (HIV)). In conclusion, non-HIV status, initial CSF OP greater than or equal to 25 cm H2O, and the presence of hydrocephalus are indicators of the future necessity for permanent shunt therapy.

Entities:  

Mesh:

Year:  2017        PMID: 28820702      PMCID: PMC5817758          DOI: 10.4269/ajtmh.17-0177

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  Shunt surgery for hydrocephalus complicating cryptococcal meningitis in human immunodeficiency virus-negative patients.

Authors:  Po-Chou Liliang; Cheng-Loong Liang; Wen-Neng Chang; Han-Jung Chen; Thung-Ming Su; Kang Lu; Cheng-Hsien Lu
Journal:  Clin Infect Dis       Date:  2003-08-12       Impact factor: 9.079

2.  Shunting in cryptococcal meningitis.

Authors:  Jacob Cherian; Robert L Atmar; Shankar P Gopinath
Journal:  J Neurosurg       Date:  2015-10-30       Impact factor: 5.115

Review 3.  Radiologic evaluation of pediatric hydrocephalus.

Authors:  Alp Dinçer; M Memet Özek
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

4.  The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis.

Authors:  Graeme F Woodworth; Matthew J McGirt; Michael A Williams; Daniele Rigamonti
Journal:  Surg Neurol       Date:  2005-06

5.  Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures.

Authors:  Tihana Bicanic; Annemarie E Brouwer; Graeme Meintjes; Kevin Rebe; Direk Limmathurotsakul; Wirongrong Chierakul; Praprit Teparrakkul; Angela Loyse; Nicholas J White; Robin Wood; Shabbar Jaffar; Thomas Harrison
Journal:  AIDS       Date:  2009-03-27       Impact factor: 4.177

6.  Cryptococcal infections in non-HIV-infected patients.

Authors:  Peter G Pappas
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

Review 7.  Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome.

Authors:  D W Denning; R W Armstrong; B H Lewis; D A Stevens
Journal:  Am J Med       Date:  1991-09       Impact factor: 4.965

Review 8.  Epidemiology and management of cryptococcal meningitis: developments and challenges.

Authors:  Read Pukkila-Worley; Eleftherios Mylonakis
Journal:  Expert Opin Pharmacother       Date:  2008-03       Impact factor: 3.889

9.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

10.  Clinical study of 23 pediatric patients with cryptococcosis.

Authors:  F-L Luo; Y-H Tao; Y-M Wang; H Li
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015-10       Impact factor: 3.507

View more
  2 in total

1.  A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States.

Authors:  Kieren A Marr; Yifei Sun; Andrej Spec; Na Lu; Anil Panackal; John Bennett; Peter Pappas; Darin Ostrander; Kausik Datta; Sean X Zhang; Peter R Williamson
Journal:  Clin Infect Dis       Date:  2020-01-02       Impact factor: 9.079

2.  Factors Associated With Ventriculoperitoneal Shunt Placement in Patients With Cryptococcal Meningitis.

Authors:  John W Baddley; George R Thompson; Kristen O Riley; Mary K Moore; Stephen A Moser; Peter G Pappas
Journal:  Open Forum Infect Dis       Date:  2019-05-20       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.